*Bioequivalence studies
- conducting a variety of BE study designs, including Cross-over, parallel, partial replicate, full replicate, fast and fed studies.
- An effective system for recruiting that ensures the application of the strictest eligibility rules and has a large database of fit volunteers chosen through a thorough screening procedure
- All research is carried out in accordance with the Egyptian Drug Authority (EDA) regulations, updated SOPs, good clinical practice (GCP), good laboratory practice (GLP), and protocols approved by the institutional review board (IRB).
- The Quality Assurance (QA) unit audits and validates each action.
- The MSA Bioequivalence Center employs the most recent advances in mass spectrometry (MS) and highperformance liquid chromatography (HPLC) to provide highly sensitive and selective drug and metabolite testing
*Biowaiver studies
MSA Bioequivalence center possesses a fully functional in vitro equipment for doing comparative dissolutions tests, investigations are carried out in compliance with the most recent international recommendations for biowaiver of bioequivalency studies, which are based either on dosage proportionality or the biopharmaceutical categorization system (BCS).
Inside MSA University Campus “26 July Mehwar Road intersection with Wahat Road, 6th October City. Egypt.”
Dr/Dina Karam
Center Manager
+0201129801960
Dr/ Aya Badr
Quality Assurance Manager
+0201112006907
Hotline : 16672
Mail us
This email address is being protected from spambots. You need JavaScript enabled to view it.
Bioequivalence Center - Contacts
26 July Mehwar Road intersection with Wahat Road, 6th October City. Egypt.
Tel. : (+202) 38371534-5-7/ Ext: 5146
Fax : (+202) 38371534-5-7 /Ext: 5143
Hotline : 16672